Search
Subscribe
Latest Stories
Business
Legal
Pipeline
Research
Events
Products
Clinical Articles
Ocular Surface
Contact Lenses
Glaucoma
Retina
Pediatrics
SEE MORE »
Jobs
Optometrist Jobs
Ophthalmologist Jobs
Optician & Technician Jobs
Hiring Services for Employers
SEE ALL JOBS »
Virtual Events
Upcoming Events
Clinical Trials
Stories
Business
Legal
Pipeline
Research
Events
Products
Archives
See All Stories
Resources
Reports
Cheat Sheets
Ultimate Guides
Calculators & Tools
See All Resources
Events
Courses
Jobs
Search Eyecare Jobs
Hiring Services for Employers
Published Date
Clear
Start Date
End Date
Category
Pipeline
1
Organizations
Bausch + Lomb
72
Eyes On Eyecare
55
Alcon, Inc.
49
American Optometric Association
38
Harrow
32
Glaukos
30
Topcon Healthcare
26
Regeneron
25
Aldeyra Therapeutics
21
Coopervision
19
Tags
Clinical Trials
1
Injections
1
Thyroid Eye Disease (ted)
1
Organizations:
Acelyrin, Inc.
✕
Clear all
Pipeline
Acelyrin announces phase 2 data and phase 3 design for TED therapy
Clinical findings support lonigutamab as the first subcutaneous anti-IGF-1R to demonstrate robust efficacy in TED patients comparable to IV-administered standard of care.
